Nucleic Acid Isolation and Purification Kits Market

The nucleic acid isolation and purification kits market is anticipated to reach USD 4.82 billion by 2030 from USD 3.02 billion in 2025, at a CAGR of 9.8% during the forecast period. The nucleic acid isolation and purification kits market is largely influenced by the continued expansion of molecular diagnostics and the increasing volume of PCR/RT-PCR and sequencing-based testing in clinical and research laboratories.

The nucleic acid isolation and purification kits market is competitive. Prominent players in the nucleic acid isolation and purification kits market are Thermo Fisher Scientific Inc. (US), QIAGEN (Germany), F. Hoffman-La Roche Ltd. (Switzerland), and Merck KGaA (Germany).

To know about the assumptions considered for the study download the pdf brochure

In September 2023, QIAGEN launched two new nucleic acid extraction kits: the QIAwave RNeasy Plus Mini Kit and QIAwave DNA/RNA Mini Kit, eco-friendlier versions of the RNeasy Plus Mini Kit and the All DNA/RNA Mini Kit. INOVIQ and Promega Corporation announced a global joint marketing agreement for EXO-NET exosome isolation and nucleic acid purification solutions.

Thermo Fisher Scientific Inc. (US) maintains a strong position in the nucleic acid isolation and purification kits market, due to its extensive extraction portfolio and significant presence in both clinical and research laboratories. The company offers widely used DNA/RNA extraction kits, including MagMAX magnetic bead kits for high-throughput workflows and other kit formats for routine prep across sample types. It also benefits from a tight workflow fit with KingFisher systems, which drives repeat pull-through of compatible reagent kits in automated labs.

QIAGEN, based in Germany, maintains a strong presence in the nucleic acid isolation and purification kits market with one of the broadest extraction portfolios available. The company offers kit families, such as QIAamp, DNeasy, and RNeasy, for DNA/RNA extraction from various sample types, including blood, swabs, tissue, saliva, and FFPE samples. QIAGEN also benefits from strong demand through its automation platforms such as QIAsymphony, QIAcube, and EZ1, which anchor repeat purchases of compatible kits in routine lab workflows. Its solutions are used heavily across hospitals and diagnostic labs, reference labs, public health labs, and research centers, where reproducibility and contamination control are critical.

F. Hoffman-La Roche Ltd. (Switzerland) has a strong presence in the nucleic acid isolation and purification kits market through its Diagnostics business and its large installed base in clinical labs. The company is preferred for automated extraction workflows, supported by platforms such as MagNA Pure and integrated sample prep within cobas molecular testing systems. These setups drive repeat demand for Roche-compatible extraction reagents in high-volume end-use settings. Roche solutions are used widely across hospital labs, reference labs, and public health labs. This is mainly for infectious disease testing and other routine molecular assays.

Market Ranking

The nucleic acid isolation and purification kits market is competitive. End users are prioritizing consistent yield and purity, low inhibitor carryover, and repeatable performance across batches because extraction quality directly impacts PCR and NGS results. QIAGEN is a leader due to its broad kit portfolio (spin columns and magnetic beads), deep protocol library, and strong adoption across hospital labs and research centers. Its installed base of sample prep automation further supports repeat kit demand. Thermo Fisher Scientific remains a leading player, offering high-throughput MagMAX kits and strong pull-through from KingFisher automation, making it a preferred choice for scaled molecular laboratories. Roche Diagnostics is another key leader, supported by its clinical lab footprint and automated extraction workflows that fit routine molecular testing.

Related Reports:

Nucleic Acid Isolation and Purification Kits Market by Type (DNA, RNA, Total Nucleic Acid, Others), Method (Column, Magnetic Beads, Reagent), Application (Diagnostics, Personalized Medicine), End User (Pharma & Biotech, CROs) – Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com